Clinical Trial

Munich Long COVID Registry for Children, Adolescents, and Adults

Study acronym: MLC-R
Recruiting
View on ClinicalTrials.gov →
Summary
The MLC-R aims to create a large-scale registry that provides data on epidemiology, phenotypes, and disease trajectories of and health care for Long COVID at any age in Germany, which can be used for future clinical trials.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-12-05; most recent amendment 2024-02-14.
Trial Details
NCT Number NCT05638724
Lead Sponsor Technical University of Munich
Collaborators: Charite University, Berlin, Germany, Ruhr University of Bochum, Technische Universität Dresden, University of Freiburg, University of Hamburg-Eppendorf, Leipniz University Hannover, Germany., Saarland University Homburg,Germany., University of Jena, University of Kassel, Germany., University of Cologne
Conditions Post-COVID Condition
Enrollment 1,000 participants
Start Date 2022-07-20
Primary Completion 2027-07-20 (estimated)
Study Completion 2027-07-20 (estimated)
Updated on ClinicalTrials.gov 2024-02-15